Drug intelligence / Profile preview

Kavibrain Suspension

Development stage
Unknown
Lead developer
Kaviva Life Sciences
Administration
Oral
01

Overview

Kavibrain Suspension is an oral pediatric nutraceutical product from Kaviva formulated as a multi-ingredient nutritional suspension containing l-carnosine, eicosapentaenoic acid, docosahexaenoic acid, and vitamin D3. It is marketed as nutritional brain support intended to support brain development, cognitive function, neural health, and general neurodevelopmental nutrition, particularly in children with autism spectrum disorder, learning difficulties, speech delay, attention concerns, and developmental delay. Its proposed mechanism is non-target-specific nutritional supplementation: l-carnosine is positioned as a neuronal support and antioxidant nutrient, while the omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and vitamin D3 are intended to provide membrane, neurodevelopmental, and micronutrient support rather than acting as a conventional pharmaceutical targeted therapy.

Brand names
Kavibrain Suspension
Other names
Kavibrain

Beyond the preview

Go deeper on Kavibrain Suspension.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kavibrain Suspension.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call